all-Trans-retinoic acid reduces neointimal formation and promotes favorable geometric remodeling of the rat carotid artery after balloon withdrawal injury

Circulation

Volumn 98, Issue 12, 1998, Pages 1219-1227

  Miano, Joseph M ^a   Kelly, Louise A ^a   Artacho, Cecilia A ^b   Nuckolls, Tammy A ^a   Piantedosi, Roseann ^b   Blaner, William S ^b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b Columbia University ^*  (United States)

Author keywords

Actins; Cells; Muscle, smooth; Restenosis; Retinoids; Revascularization

Indexed keywords

DNA; RETINOIC ACID;

ANIMAL MODEL; ANIMAL TISSUE; ARTERY INJURY; ARTICLE; CAROTID ARTERY DISEASE; CONTROLLED STUDY; DNA SYNTHESIS; DRUG BLOOD LEVEL; DRUG TISSUE LEVEL; GEOMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTIMA; MALE; MORPHOMETRICS; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; REVASCULARIZATION;

EID: 0032558415     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.98.12.1219     Document Type: Article

References (57)

1. Schwartz SM, deBlois D, O'Brien ERM. The intima: soil for atherosclerosis and restenosis. Circ Res. 1995;77:445-465.
2. Buck RC. Intimal thickening after ligation of arteries. Circ Res. 1961;9: 418-426.
3. Murray M, Schrodt GR, Berg HF. Role of smooth muscle cells in healing of injured arteries. Arch Pathol. 1966;82:138-146.
4. Bjorkerud S. Reaction of the aortic wall of the rabbit after superficial, longitudinal, mechanical trauma. Virchows Arch A Pathol Anat Histol. 1969;347:197-210.
5. Stemerman MB, Ross R. Experimental arteriosclerosis, I: fibrous plaque formation in primates: an electron microscope study. J Exp Med. 1972; 136:769-789.
6. Fishman J, Ryan GB, Karnovsky MJ. Endothelial regeneration in the rat carotid artery and the significance of endothelial denudation in the pathogenesis of myointimal thickening. Lab Invest. 1975;32:339-351.
7. Clowes AW, Schwartz SM. Significance of quiescent smooth muscle migration in the injured rat carotid artery. Circ Res. 1985;56:139-145.
8. Mosse P, Campbell GR, Wang ZL, Campbell JH. Smooth muscle phenotypic expression in human carotid arteries. I: comparison of cells from diffuse intimal thickenings adjacent to atheromatous plaques with those of the media. Lab Invest. 1985;53:556-562.
9. Isner JM, Kearney M, Bauters C, Leclerc G, Nikol S, Pickering JG, Riessen R, Weir L. Use of human tissue specimens obtained by directional atherectomy to study restenosis. Trends Cardiovasc Med. 1994;4: 213-221.
10. Landzberg BR, Frishman WH, Lerrick K. Pathophysiology and pharmacological approaches for prevention of coronary artery restenosis following coronary artery balloon angioplasty and related procedures. Prog Cardiovasc Dis. 1997;39:361-398.
11. Lefkovits J, Topol EJ. Pharmacological approaches for the prevention of restenosis after percutaneous coronary intervention. Prog Cardiovasc Dis. 1997;40:141-158.
12. Kuntz RE, Baim DS. Defining coronary restenosis: newer clinical and angiographic paradigms. Circulation. 1993;88:1310-1323.
13. Glagov S. Intimal hyperplasia, vascular modeling, and the restenosis problem. Circulation. 1994;89:2888-2891.
14. Sporn MB, Dunlop NM, Newton DL, Smith JM. Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids). Fed Proc. 1976;35:1332-1338.
15. Mangelsdorf DJ, Umesono K, Evans RM. The retinoid receptors. In: Sporn MB, Roberts AB, Goodman DS, eds. The Retinoids: Biology, Chemistry; and Medicine. New York, NY: Raven Press; 1994:319-349.
16. Strickland S, Mahdavi V. The induction of differentiation in teratocarcinoma stem cells by retinoic acid. Cell. 1978;15:393-403.
17. van Giezen JJ, Boon GI, Jansen JW, Bouma BN. Retinoic acid enhances fibrinolytic activity in-vivo by enhancing tissue type plasminogen activator (t-PA) activity and inhibits venous thrombosis. Thromb Haemost. 1993;69:381-386.
18. Fanjul A, Dawson MI, Hobbs PD, Jong L, Cameron JF, Harlev E, Graupner G, Lu XP, Pfahl M. A new class of retinoids with selective inhibition of AP-1 inhibits proliferation. Nature. 1994;372:107-110.
19. James TW, Wagner R, White LA, Zwolak RM, Brinckerhoff CE. Induction of collagenase and stromelysin gene expression by mechanical injury in a vascular smooth muscle-derived cell line. J Cell Physiol. 1993;157:426-437.
20. Ishii H, Horie S, Kizaki K, Kazama M. Retinoic acid counteracts both the downregulation of thrombomodulin and the induction of tissue factor in cultured human endothelial cells exposed to tumor necrosis factor. Blood. 1992;80:2556-2562.
21. Lingen MW, Polverini PJ, Bouch NP. Inhibition of squamous cell carcinoma angiogenesis by direct interaction of retinoic acid with endothelial cells. Lab Invest. 1996;74:476-483.
22. Mukherjee G, Chatterjee GC. Differential effect of retinoic acid on ADP and collagen induced platelet aggregation. Indian J Exp Med. 1990;28: 949-952.
23. Gillie J, Paxton LLL, Lawley TJ, Caughman SW, Swerlick RA. Retinoic acid inhibits the regulated expression of vascular cell adhesion molecule-1 by cultured dermal microvascular endothelial cells. J Clin Invest. 1997;99:492-500.
24. Lippman SM, Heyman RA, Kurie JM, Benner SE, Hong WK. Retinoids and chemoprevention: clinical and basic studies. J Cell Biochem. 1995; 22:1-10.
25. Tallman MS, Anderson JW, Schiffer CA, Appelbaum FR, Feusner JH, Ogden A, Shepherd L, Willman C, Bloomfield CD, Rowe JM, Wiernik PH. all-trans Retinoic acid in acute promyelocytic leukemia. N Engl J Med. 1997;337:1021-1028.
26. Miano JM, Topouzis S, Majesky MW, Olson EN. Retinoid receptor expression and all-trans retinoic acid-mediated growth inhibition in vascular smooth muscle cells. Circulation. 1996;93:1886-1895.
27. Kato S, Sasaguri Y, Morimatsu M. Down-regulation in the production of matrix metalloproteinase 1 by human aortic intimal smooth muscle cells. Biochem Mol Biol Int. 1993;31:239-248.
28. Hayashi A, Suzuki T, Tajima S. Modulations of elastin expression and cell proliferation by retinoids in cultured vascular smooth muscle cells. J Biochem. 1995;117:132-136.
29. Pakala R, Davies PJA, Chandraratna R, Benedict CR. all trans-Retinoic acid and its derivatives inhibit serotonin-induced vascular smooth muscle cell proliferation. J Am Coll Cardiol. 1995;25:83A-84A. Abstract.
30. Libby P, Tanaka H. The molecular bases of restenosis. Prog Cardiovasc Dis. 1997;40:97-106.
31. Clowes AW, Reidy MA, Clowes MM. Kinetics of cellular proliferation after arterial injury, I: smooth muscle growth in the absence of endothelium. Lab Invest. 1983;49:327-333.
32. Boettger-Tong H, Stancel GM. Retinoic acid inhibits estrogen-induced uterine stromal and myometrial cell proliferation. Endocrinology. 1995; 136:2975-2983.
33. Kurlandsky SB, Gamble MV, Ramakrishnan R, Blaner WS. Plasma delivery of retinoic acid to tissues in the rat. J Biol Chem. 1995;270: 17850-17857.
34. London SM, Mayberg MR. Kinetics of bromodeoxyuridine uptake by smooth muscle cells after arterial injury. J Vasc Res. 1994;31:247-255.
35. Morris DL, Kritchevsky SB, Davis CE. Serum carotenoids and coronary heart disease: the Lipid Research Clinics Coronary Prevention Trial and Follow-up Study. JAMA. 1994;272:1439-1441.
36. Pandey DK, Shekelle R, Selwyn BJ, Tangey C, Stamler J. Dietary vitamin C and β-carotene and risk of death in middle-aged men: the Western Electric Study. Am J Epidemiol. 1995;142:1269-1278.
37. Shaish A, Daugherty A, O'Sullivan F, Schonfeld G, Heinecke JW. Beta-carotene inhibits atherosclerosis in hypercholesterolemic rabbits. J Clin Invest. 1995;96:2075-2082.
38. Greenberg EB, Baron JA, Karagas MR, Stukel TA, Nierenberg DW, Stevens MM, Mandel JS, Haile RW. Mortality associated with low plasma concentration of beta carotene and the effect of oral supplementation. JAMA. 1996;275:699-703.
39. Hennekens CH, Buring JE, Manson JE, Stampfer M, Rosner B, Cook NR, Belanger C, LaMotte F, Gaziano JM, Ridker PM, Willett W, Peto R. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med. 1996;334:1145-1149.
40. Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, Keogh JP, Meyskens FL, Valanis B, Williams JH Jr, Barnhart S, Hammar S. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med. 1996;334: 1150-1155.
41. Rapola JM, Virtamo J, Ripatti S, Huttunen JK, Albanes D, Taylor PR, Heinonen OP. Randomized trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction. Lancet. 1997;349:1715-1720.
42. Burchenal JEB, Keaney JF, Curran-Celentano J, Gaziano JM, Vita JA. The lack of effect of beta-carotene on restenosis in cholesterol-fed rabbits. Atherosclerosis. 1996;123:157-167.
43. Blaner WS, Olson JA. Retinol and retinoic acid metabolism. In: Sporn MB, Roberts AB, Goodman DS, eds. The Retinoids: Biology, Chemistry, and Medicine. New York, NY: Raven Press; 1994:229-255.
44. Collins MD, Tzimas G, Burgin H, Hummler H, Nau H. Single versus multiple dose administration of all-trans retinoic acid during organogenesis: differential metabolism and transplacental kinetics in rat and rabbit. Toxicol Appl Pharmacol. 1995;130:9-18.
45. Muindi JRF, Young CW, Warrell RP. Clinical pharmacology of all-trans retinoic acid. Leukemia. 1994;8:1807-1812.
46. Gillis JC, Goa KL. Tretinoin: a review of its pharmacodynamic and pharmacokinetic properties and use in the management of acute promyelocytic leukaemia. Drugs. 1995;50:897-923.
47. Casscells W. Migration of smooth muscle and endothelial cells: critical events in restenosis. Circulation. 1992;86:723-729.
48. Schwartz SM, Reidy MA, O'Brien ERM. Assessment of factors important in atherosclerotic occlusion and restenosis. Thromb Haemost. 1995;74:541-551.
49. Bochaton-Piallat ML, Gabbiani F, Redard M, Desmouliere A, Gabbiani G. Apoptosis participates in cellularity regulation during rat aortic intimal thickening. Am J Pathol. 1995;146:1059-1064.
50. Han DKM, Haudenschild CC, Hong MK, Tinkle BT, Leon MB, Liau G. Evidence for apoptosis in human atherogenesis and in a rat vascular injury model. Am J Pathol. 1995;147:267-277.
51. Perlman H, Maillard L, Krasinski K, Walsh K. Evidence for the rapid onset of apoptosis in medial smooth muscle cells after balloon injury. Circulation. 1997;95:981-987.
52. Nagy L, Thomazy VA, Chandraratna R, Heyman RA, Davies PJA. Retinoid-regulated expression of bcl-2 and tissue transglutaminase during the differentiation and apoptosis of human myeloid leukemia (HL-60) cells. Leuk Res. 1996;20:499-505.
53. Clowes AW, Reidy MA, Clowes MM. Mechanisms of stenosis after arterial injury. Lab Invest. 1983;49:208-215.
54. Zalewski A, Shi Y. Vascular myofibroblasts: lessons from coronary repair and remodeling. Arterioscler Thromb Vasc Biol. 1997;17:417-422.
55. Shi Y, Pieniek M, Fard A, O'Brien J, Mannion JD, Zalewski A. Adventitial remodeling after coronary arterial injury. Circulation. 1996;93: 340-348.
56. Scott NA, Cipolla GD, Ross CE, Dunn B, Martin FH, Simonet L, Wilcox JN. Identification of a potential role for the adventitia in vascular lesion formation after balloon overstretch injury of porcine coronary arteries. Circulation. 1996;93:2178-2187.
57. Sarembock IJ. Retinoic acid and restenosis. Paper presented at: Restenosis Summit IX, Cleveland Clinic; 1997; Cleveland, Ohio.